Literature DB >> 15251261

Antidepressant effects of ERbeta-selective estrogen receptor modulators in the forced swim test.

Alicia A Walf1, Madeline E Rhodes, Cheryl A Frye.   

Abstract

Estradiol (E2) may influence depressive symptomology of women and decrease depressive behavior among rodents. The mechanism(s) for E2's antidepressant effects are not well understood. To determine whether antidepressant effects of E2 may involve actions at intracellular estrogen receptor (ER) alpha or beta isoforms, selective ER modulators (SERMs) were administered (10 microg sc) to ovariectomized rats 48 h before testing in the forced swim test, an animal model of depression, and the horizontal crossing task. Rats received sesame oil vehicle, 17beta-E2, which has a high affinity for ERalpha and ERbeta, SERMs that vary in their activity at ERalpha and beta, or a tricyclic antidepressant (desipramine; 30 mg/kg ip), as a positive control. ERalpha-selective SERMs were propyl pyrazole triol (PPT) and 17alpha-E2. PPT has more selective effects at ERalpha than does 17alpha-E2, which also binds ERbeta. ERbeta-selective SERMs were diarylpropionitrile (DPN) and 7,12-dihydrocoumestan (coumestrol). DPN is more selective at ERbeta than coumestrol, which also binds ERalpha. 17beta-E2, ERbeta-selective SERMs (DPN, coumestrol), and desipramine administration produced antidepressive behavior (decreased immobility, increased struggling and swimming). ERalpha-selective SERMs (PPT, 17alpha-E2) were not different from vehicle. There were no differences among groups in the number of beam breaks made in the horizontal crossing task. These data suggest that E2's antidepressive effects may involve actions at ERbeta.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15251261     DOI: 10.1016/j.pbb.2004.03.023

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  67 in total

Review 1.  Estrogen receptors and the regulation of neural stress responses.

Authors:  Robert J Handa; Shaila K Mani; Rosalie M Uht
Journal:  Neuroendocrinology       Date:  2012-09-14       Impact factor: 4.914

2.  Parity and estrogen-administration alter affective behavior of ovariectomized rats.

Authors:  Alicia A Walf; Cheryl A Frye
Journal:  Physiol Behav       Date:  2007-09-25

Review 3.  Sex differences in psychopathology: of gonads, adrenals and mental illness.

Authors:  Matia B Solomon; James P Herman
Journal:  Physiol Behav       Date:  2009-03-09

4.  Effects of Long-Term Treatment with Estradiol and Estrogen Receptor Subtype Agonists on Serotonergic Function in Ovariectomized Rats.

Authors:  Saloua Benmansour; Opeyemi S Adeniji; Anthony A Privratsky; Alan Frazer
Journal:  Neuroendocrinology       Date:  2015-07-01       Impact factor: 4.914

5.  Chronic treatment with estrogen receptor agonists restores acquisition of a spatial learning task in young ovariectomized rats.

Authors:  R Hammond; R Mauk; D Ninaci; D Nelson; R B Gibbs
Journal:  Horm Behav       Date:  2009-06-25       Impact factor: 3.587

Review 6.  Oestrogen receptor beta is involved in the actions of oestrogens in the brain for affective behaviour, but not trophic effects in peripheral tissues.

Authors:  A A Walf
Journal:  J Neuroendocrinol       Date:  2009-12-15       Impact factor: 3.627

Review 7.  The role of reproductive hormones in postpartum depression.

Authors:  Crystal Edler Schiller; Samantha Meltzer-Brody; David R Rubinow
Journal:  CNS Spectr       Date:  2014-09-29       Impact factor: 3.790

Review 8.  Estrogen therapy and cognition: a review of the cholinergic hypothesis.

Authors:  Robert B Gibbs
Journal:  Endocr Rev       Date:  2009-12-17       Impact factor: 19.871

Review 9.  Sex hormones and mood in the perimenopause.

Authors:  Peter J Schmidt; David R Rubinow
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

Review 10.  Rapid and estrogen receptor beta mediated actions in the hippocampus mediate some functional effects of estrogen.

Authors:  Alicia A Walf; Cheryl A Frye
Journal:  Steroids       Date:  2008-02-09       Impact factor: 2.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.